<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46795">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02497040</url>
  </required_header>
  <id_info>
    <org_study_id>uludagu</org_study_id>
    <nct_id>NCT02497040</nct_id>
  </id_info>
  <brief_title>The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine</brief_title>
  <official_title>Effects of Scalp Block With Bupivacaine Versus Levobupivacaine on Haemodynamic Response to Head Pinning and Efficacy on Postoperative Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uludag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uludag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ninety American Society of Anesthesiologists (ASA) Physical Status classification system
      I-II patients were recruited for a randomised, placebo-controlled, double-blind study and
      were randomly divided into three groups to receive either 20 ml of 0.5% bupivacaine (Group
      B; n=30), 20 ml of 0.5% levobupivacaine (Group L; n=30) or saline as a placebo (Group C;
      n=30). Scalp block was performed 5 min before head pinning. Systolic, diastolic and mean
      arterial pressure (MAP), heart rate (HR), peripheral oxygen saturation and end-tidal carbon
      dioxide were recorded. Postoperative pain was evaluated using a 10-cm visual analogue scale
      (VAS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following approval from the Research Ethics Committee of the Medical Faculty of UludaÄŸ
      University, (the date and protocol number assigned by this ethics committee were March 4,
      2008 and 5/30, respectively),written informed consent was obtained from patients undergoing
      elective scheduled operations involving craniotomy during anaesthesia consultations. Ninety
      American Society of Anesthesiologists (ASA) Physical Status classification system I or II
      patients of either sex between 18-85 years of age were allocated to this randomised,
      prospective, placebo-controlled, double-blind study. The patients were randomly divided into
      three groups using a sealed-enveloped technique to receive either 20 ml of 0.5% bupivacaine
      (Group B (n=30)), 20 ml of 0.5% levobupivacaine (Group L (n=30)) or saline as a placebo
      (Group C (n=30)). Twenty-millilitre syringes for the block were prepared and numbered by a
      blinded assistant.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in mean arterial pressure</measure>
    <time_frame>220+-70 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>10-cm visual analogue scale (VAS)</measure>
    <time_frame>0-24 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in heart rate</measure>
    <time_frame>220+-70 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in diastolic arterial pressure</measure>
    <time_frame>220+-70 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in systolic arterial pressure</measure>
    <time_frame>220+-70 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>bupivacaine,levobupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 ml of 0.5% bupivacaine 20 ml of 0.5% levobupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 ml of 0.5% levobupivacaine saline as a placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 ml of 0.5% levobupivacaine saline as a placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>local injection</description>
    <arm_group_label>bupivacaine,levobupivacaine</arm_group_label>
    <arm_group_label>levobupivacaine</arm_group_label>
    <other_name>chirocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>local injection</description>
    <arm_group_label>bupivacaine,levobupivacaine</arm_group_label>
    <arm_group_label>bupivacaine</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>local injection</description>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_label>bupivacaine</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) Physical Status classification system 1-2

        Exclusion Criteria:

          -  Uncontrolled hypertension, arrhythmia, diabetes mellitus or coagulopathy, coronary
             artery disease or a proven or suspected allergy to bupivacaine or levobupivacaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hulya bilgin</last_name>
    <role>Study Director</role>
    <affiliation>uludag university anaesthesia and reanimation department</affiliation>
  </overall_official>
  <reference>
    <citation>Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec;83(6):1256-61.</citation>
    <PMID>8942596</PMID>
  </reference>
  <reference>
    <citation>Agarwal A, Sinha PK, Pandey CM, Gaur A, Pandey CK, Kaushik S. Effect of a subanesthetic dose of intravenous ketamine and/or local anesthetic infiltration on hemodynamic responses to skull-pin placement: a prospective, placebo-controlled, randomized, double-blind study. J Neurosurg Anesthesiol. 2001 Jul;13(3):189-94.</citation>
    <PMID>11426091</PMID>
  </reference>
  <reference>
    <citation>Costello TG, Cormack JR, Mather LE, LaFerlita B, Murphy MA, Harris K. Plasma levobupivacaine concentrations following scalp block in patients undergoing awake craniotomy. Br J Anaesth. 2005 Jun;94(6):848-51. Epub 2005 Apr 7.</citation>
    <PMID>15817709</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 9, 2015</lastchanged_date>
  <firstreceived_date>July 2, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uludag University</investigator_affiliation>
    <investigator_full_name>banu otlar can</investigator_full_name>
    <investigator_title>anesthesia and reanimation</investigator_title>
  </responsible_party>
  <keyword>craniotomy</keyword>
  <keyword>local anesthetics</keyword>
  <keyword>scalp block</keyword>
  <keyword>head pinning</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
